WordNet

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. バーター症候群およびギテルマン症候群 bartter and gitelman syndromes
2. 代謝性アルカローシスの臨床症状および評価 clinical manifestations and evaluation of metabolic alkalosis
3. 嚢胞性線維症：臨床症状および診断 cystic fibrosis clinical manifestations and diagnosis
4. 代謝性アルカローシスの病因 pathogenesis of metabolic alkalosis
5. 赤血球水分量の制御 control of red blood cell hydration

Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.

May LT1, Avlani VA, Langmead CJ, Herdon HJ, Wood MD, Sexton PM, Christopoulos A.
Molecular pharmacology.Mol Pharmacol.2007 Aug;72(2):463-76. Epub 2007 May 24.
The M2 muscarinic acetylcholine receptor (mAChR) possesses at least one binding site for allosteric modulators that is dependent on the residues (172)EDGE(175), Tyr(177), and Thr(423). However, the contribution of these residues to actions of allosteric agonists, as opposed to modulators, is unknown
PMID 17525129

Screening procedure for eight quaternary nitrogen muscle relaxants in blood by high-performance liquid chromatography-electrospray ionization mass spectrometry.

Cirimele V1, Villain M, Pépin G, Ludes B, Kintz P.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.J Chromatogr B Analyt Technol Biomed Life Sci.2003 Jun 5;789(1):107-13.
A screening procedure was developed for the identification and the quantification of eight quaternary nitrogen muscle relaxants, including d-tubocurarine, alcuronium, pancuronium, vecuronium, atracurium, mivacurium, rocuronium and mebezonium, in blood samples. The procedure involves ion-pair extract
PMID 12726849

Synthesis and structure-activity relationships of neuromuscular blocking agents.

Tuba Z1, Maho S, Vizi ES.
Current medicinal chemistry.Curr Med Chem.2002 Aug;9(16):1507-36.
The first use of neuromuscular blocking agents (muscle relaxants) in clinical practice (1942) revolutionised the practice of anaesthesia and started the modern era of surgery. Since 1942 introduction of tubocurarine (18) neuromuscular blocking agents have been used routinely to provide skeletal musc
PMID 12171561